SUMMARY GASTROINTESTINAL MANIFESTATION AND OUTCOME OF HENOCH - SCHöNLEIN PURPURA IN CHILDREN
Main Article Content
Abstract
Background: Henoch - Schönlein pupura (HSP) is a systemic vasculitis with inflammatory lesions by the deposition of IgA - containing immune complex in the wall of small blood vessel. HSP characterized by nonthrombocytopenic palpable purpura, arthritis and abdominal pain. Gastrointestinal involvement (GI) is common and causes of HSP hospitalization. HSP is typically good prognosis, but some patients develop severe complications as gastrointestinal bleeding or glomerulonephritis. Methods: It was a case series study in 134 childrens with the first diagnosis of gastrointestinal involvement of HSP admitted to National Children's Hospital from 7/ 2020 to 6/ 2021 and extended for 3 months follow- up. Results: The median age of HSP was 7 years old. Abdominal pain in 100% cases. GI symptoms occurred before the manifestation of skin lession in 35,8% cases. Severe complications included gastrointestinal bleeding (44%), intussusception and acute pancreatitis. Overall outcome were good with self- limited in 1 to 4 weeks. Renal involvement often occurred during 1week to 1 month afer the disease onset. After 3 months, renal involvement decreased. Relapses occurred in 28,4% children. Conclusions: The overall outcome of GI involvement in children with HSP remains good. However, children with HSP should perform urinalysis regulary for early protection of complication.
Article Details
Keywords
Henoch-Schönlein pupura, abdominal, Gastrointestinal involvement (GI), children
References
2. Yang Y-H, Yu H-H, Chiang B-L. The diagnosis and classification of Henoch–Schönlein purpura: An updated review. Autoimmunity Reviews. 2014;13(4-5):355-358. doi:10.1016/j.autrev.2014.01.031
3. Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Annals of the Rheumatic Diseases. 2010;69(5):798-806. doi:10.1136/ard.2009.116657
4. Chen S-Y, Kong M-S. Gastrointestinal manifestations and complications of Henoch-Schönlein purpura. Chang Gung Med J. 2004; 27(3):175-181.
5. Calvo-Río V, Hernández JL, Ortiz-Sanjuán F, et al. Relapses in patients with Henoch–Schönlein purpura: Analysis of 417 patients from a single center. Medicine. 2016;95(28):e4217. doi:10.1097/ MD.0000000000004217
6. Shah G. Clinical profile and pattern of Henoch-Schönlein purpura in children. J Patan Acad Health Sci. 2015;2(1):17-21. doi:10.3126/ jpahs. v2i1.20335
7. Ekinci RMK, Balci S, Sari Gokay S, et al. Do practical laboratory indices predict the outcomes of children with Henoch-Schönlein purpura? Postgrad Med. 2019;131(4):295-298. doi:10.1080/ 00325481.2019.1609814
8. Ozen S, Bilginer Y. Henoch-Schönlein purpura/immunoglobulin-A vasculitis. In: Rheumatology. Elsevier; 2015:1338-1343. doi:10.1016/B978-0-323-09138-1.00161-3